CARMA For Life vs The Difficult Airway App Usage & Stats

CARMA, the Cardiac Arrest Resuscitation Mobile Application, is an ACLS tool designed to help guide practitioners through bedside resuscitation. Preliminary trials using the algorithm presented in CARMA has resulted in an 80% increase in patient survival of a CPR event. CARMA has four independent countdown timers, swipe-able Ventricular Tachycardia & Ventricular Fibrillation and Pulseless Electrical Activity (PEA) reference pages. There is a complete list of select-able Diagnostic Tips (H's and T's) and recommended medication and non-medication treatment solutions. CARMA is an invaluable, portable tool for healthcare professionals in the resuscitation of patients experiencing cardiopulmonary arrest. CARMA includes an audible CPR metronome which defaults to 100 beats/minute, and timers for Epinephrine, Amniodarone and code duration. The duration timer prompts the leader to reevaluate every 30 minutes. Each timer has a unique vibrate feature when it completes its cycle. All of CARMA's timer durations, rates and audible features are configurable through CARMA's preferences menu. CARMA also features a logging process that automatically tracks all activities within a session. They include timer starts and stops, H's and T's selections, rhythm, medication and non-drug intervention selections. Each event is time stamped for easy review. In addition, the session log can be easily emailed for archiving purposes. In conformance with HIPAA requirements, no patient information is stored in the log and the log does not reside in the physical space of the mobile device. Once the application exits or is reset, the log is deleted. CARMA is an ACLS tool which gives healthcare providers the ability to better manage cardio-pulmonary events. It guides the provider through ACLS protocols in real time at the bedside utilizing the 2014 American Heart Association (AHA) guidelines, leading to better outcomes. For more information visit www.carmaforlife.com

Apple App Store
Paid
Medical

Store Rank

- -

The Difficult Airway App

The Difficult Airway App (v.3.2) The Difficult Airway App™ is an essential tool for clinicians who manage emergency airways in any setting: the ED, ICU, in-patient unit or the many EMS practice environments. THE RIGHT DRUGS, THE RIGHT DOSES, THE RIGHT WAY! This app rapidly and easily selects the right drugs for RSI, automatically adjusting for obesity and hemodynamics. Pediatric dosing and equipment selection is a snap using the Broselow-Luten color system or the child's estimated weight. Stay out of trouble! The Difficult Airway App™ guides the user quickly and easily through important algorithms, predictors of the difficult airway, and the step-by-step approach to RSI taught in The Difficult Airway Course: Emergency™. The Difficult Airway App™ features: EASY, YET SOPHISTICATED ADULT AND PEDIATRIC DRUG DOSING • For adult dosing, a few simple clicks bring you to recommended doses that incorporate patient weight, body habitus and hemodynamics. • The pediatric drug dosing function incorporates the color-coded system created by James Broselow, MD and Robert C. Luten, MD for rapid, safe management of pediatric airway cases. • The option to customize your formulary means that only the drugs you use will appear in the recommendations. DECISION-MAKING SUPPORT • Straight-forward algorithms allow you to quickly determine the best approach to your patient’s airway. • Easy mnemonics walk you through predictors of a difficult airway, including difficult laryngoscopy (LEMON), difficult BMV (ROMAN), difficult extraglottic device use (RODS) and difficult cricothyrotomy (SMART). • Pearls of wisdom, based on evidence and expert opinion, are offered throughout. RAPID SEQUENCE INTUBATION • The 7 – Ps of RSI: a step-by-step guide for adult and pediatric patients. • Adult and pediatric RSI drug dosing. EDUCATIONAL RESOURCES • Richly detailed illustrations of the airway anatomy. • Links to information about The Difficult Airway Courses™. Created by Ron M. Walls, MD, Michael F. Murphy, MD and Robert C. Luten, MD. With significant updates by Calvin A. Brown III, MD.